Impact of pre-procedural beta blockade on inpatient mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction

American Journal of Cardiology

Volumn 111, Issue 12, 2013, Pages 1714-1720

  Valle, Javier A ^a   Zhang, Min ^b   Dixon, Simon ^d   Aronow, Herbert D ^e   Share, David ^c   Naoum, Joseph B ^f   Gurm, Hitinder S ^g  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

^e ST JOSEPH MERCY HOSPITAL   (United States)

^f Henry Ford Health Systems   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLUE CROSS BLUE SHIELD; CARDIAC PATIENT; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEALTH IMPACT ASSESSMENT; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPENSITY SCORE; REPEAT PROCEDURE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ADRENERGIC ANTAGONISTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; FEMALE; HEART CONDUCTION SYSTEM; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878885844     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.02.022     Document Type: Article

References (15)

1. E. Kline-Rogers, D. Share, D. Bondie, B. Rogers, D. Karavite, S. Kanten, P. Wren, C. Bodurka, C. Fisk, J. McGinnity, S. Wright, S. Fox, K.A. Eagle, and M. Moscucci Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience J Interv Cardiol 15 2002 387 392
2. J.K. Lunceford, and M. Davidian Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study Stat Med 23 2004 2937 2960
3. P.R. Rosenbaum, and D.B. Rubin Reducing bias in observational studies using subclassification on the propensity score J Am Stat Assoc 79 1984 516 524
4. M.M. Rasmussen, K.A. Reimer, R.A. Kloner, and R.B. Jennings Infarct size reduction by propranolol before and after coronary ligation in dogs Circulation 56 1977 794 798
5. J. Herlitz, H. Emanuelsson, K. Swedberg, A. Vedin, A. Waldenstrom, J. Waldenstrom, and A. Hjalmarson Goteborg metoprolol trial: enzyme-estimated infarct size Am J Cardiol 53 suppl 1984 15D 21D
6. The MIAMI Trial Research Group Metoprolol in Acute Myocardial Infarction (MIAMI). A randomised placebo-controlled international trial Eur Heart J 6 1985 199 226
7. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
8. F. Van de Werf, L. Janssens, T. Brzostek, L. Mortelmans, F.J. Wackers, G.M. Willems, H. Heidbuchel, E. Lesaffre, I. Scheys, D. Collen, and H. De Geest Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy J Am Coll Cardiol 22 1993 407 416
9. R. Roberts, W.J. Rogers, H.S. Mueller, C.T. Lambrew, D.J. Diver, H.C. Smith, J.T. Willerson, G.L. Knatterud, S. Forman, and E. Passamani Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) II-B study Circulation 83 1991 422 437
10. Z.M. Chen, H.C. Pan, Y.P. Chen, R. Peto, R. Collins, L.X. Jiang, J.X. Xie, and L.S. Liu Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
11. E.M. Antman, M. Hand, P.W. Armstrong, E.R. Bates, L.A. Green, L.K. Halasyamani, J.S. Hochman, H.M. Krumholz, G.A. Lamas, C.J. Mullany, D.L. Pearle, M.A. Sloan, S.C. Smith Jr., Writing Committee M, D.T. Anbe, F.G. Kushner, J.P. Ornato, A.K. Jacobs, C.D. Adams, J.L. Anderson, C.E. Buller, M.A. Creager, S.M. Ettinger, J.L. Halperin, S.A. Hunt, B.W. Lytle, R. Nishimura, R.L. Page, B. Riegel, L.G. Tarkington, and C.W. Yancy 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, writing on behalf of the 2004 Writing Committee Circulation 117 2008 296 329
12. K.J. Harjai, G.W. Stone, J. Boura, L. Grines, E. Garcia, B. Brodie, D. Cox, W.W. O'Neill, and C. Grines Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction Am J Cardiol 91 2003 655 660
13. A. Halkin, C.L. Grines, D.A. Cox, E. Garcia, R. Mehran, J.E. Tcheng, J.J. Griffin, G. Guagliumi, B. Brodie, M. Turco, B.D. Rutherford, E. Aymong, A.J. Lansky, and G.W. Stone Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction J Am Coll Cardiol 43 2004 1780 1787
14. V.S. Ignjatovic, N. Petrovic, V. Miloradovic, S. Ignjatovic, V. Cokanovic, A. Grdinic, I. Simic, I. Petrovic, S. Nikolic, A. Andjelkovic, and D. Paramentic The influence of bisoprolol dose on ADP-induced platelet aggregability in patients on dual antiplatelet therapy Coron Artery Dis 21 2010 472 476
15. K. Winther, G. Gleerup, and T. Hedner Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers J Cardiovasc Pharmacol 18 suppl 1991 S41 S44